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1 Introduction 
This is the evaluation framework for Cancer Australia’s National Lung Cancer Program (NLCP) as 
proposed by the Centre for Health Service Development (CHSD), University of Wollongong. 
 
The NLCP is a new program of Cancer Australia that has been funded for an initial four year 
period from 2009 – 2013.  The total budget allocation across this period is $6.83 million. 
 
In designing the methodology for the program evaluation it is essential to be clear about the 
purpose of the evaluation.  For the NLCP, program evaluation has two key purposes to: 
 Assess progress against the program objectives and; 
 Determine if the program is operating appropriately, effectively and efficiently. 
1.1 Background 
1.1.1 Summative and formative evaluation 
In assessing progress against the NLCP objectives there are both summative and formative 
evaluation tasks.  Summative evaluation ascertains whether and to what extent the program was 
implemented as intended and the desired/anticipated results achieved.  This form of evaluation 
usually occurs near the end-point of a program.  The purpose is to ensure accountability and value 
for money with the results of the evaluation informing any future planning decisions, policy and 
resource allocation.  This is evaluation for judgement (‘How did the NLCP do?’). 
Formative evaluation more commonly occurs throughout the life of the program as it uses the 
results of the evaluation to inform the ongoing development and improvement of the program.  It 
aims to improve the program throughout its implementation.  This is evaluation for learning (‘How 
can the NLCP learn and get better as it goes?). 
Cancer Australia is committed to improving the delivery of their programs and ensuring that the 
organisation as a whole monitors performance and delivers against the outcomes documented in 
the Cancer Australia Strategic Plan 2011-20141.   
1.1.2 Lapsing program evaluation 
The NLCP has been funded by the Australian Government for a specified period.  As this funding 
period draws to a close an assessment can be made as to whether the program is meeting its 
stated objectives.  In order to secure further funding the NLCP will be subject to the Department of 
Finance and Deregulation’s evaluation requirements for ongoing funding of a lapsing or 
terminating program.  This requires an assessment of the program’s appropriateness, efficiency 
and effectiveness. 
 ‘Program evaluation involves the systematic and objective assessment of government 
programs or parts of programs, to assist the Government and other decision-makers to: 
- assess the continued relevance and priority of program objectives in the light of current 
circumstances, including government policy changes (that is, appropriateness of the 
program); 
- test whether the program outcomes achieve stated objectives (that is, its 
effectiveness); and 
                                               
1 Australian Government, Cancer Australia (August 2011). Cancer Australia: Strategic Plan 2011 – 2014. 





Page 2                                                               Cancer Australia National Lung Cancer Program: Evaluation Framework 
- ascertain whether there are better ways of achieving these objectives (that is, its 
efficiency)’.2 
1.2 Factors influencing the evaluation framework 
The design of the NLCP evaluation framework must accommodate several factors.  These include 
the distinction between monitoring and evaluation; the foundation provided by the NLCP program 
logic and the integration required with the broader performance evaluation processes within 
Cancer Australia. 
1.2.1 Monitoring and evaluation 
The NLCP will need to monitor its performance through a small suite of Key Performance 
Indicators (KPIs).  For example, the projects that are funded must operate in accordance with an 
agreed project management framework.  Each project is monitored to ensure that milestones are 
achieved and that the expected outputs are delivered.  The program as a whole has a defined 
budget allocation and officers of Cancer Australia monitor expenditure carefully throughout the 
financial year to ensure that funds are used appropriately.  Monitoring is something that occurs on 
an ongoing basis and generates data that can be used to inform the evaluation when it occurs. 
 
The evaluation framework aims to build upon these existing sources of information gathered 
through routine monitoring and data collection.  A range of additional data will need to be collected 
as a ‘snapshot’ to answer the evaluation questions that form the core of the evaluation framework.  
Suggested NLCP Key Performance Indicators for ‘monitoring’ purposes are included in Table 1 
below. 
 
Table 1 NLCP Key Performance Indicators 
 
Program Objective Key Performance Indicator 
Increasing research to build the evidence around lung 
cancer  
1. Number of NLCP publications that provide evidence to inform 
priorities for cancer control 
2. Number of citations  of NLCP funded scholarly publications 
Increasing support and guidance for health professionals 
(through clinical guidelines and evidence based 
information) 
3. Number of support and guidance projects completed on time 
and within budget 
4. Number of web hits/downloads recorded for the new model of 
care, and/or  clinical guidelines 
5. Number of health professionals participating in spaced education 
activities and/or using clinical guidelines. 
Improving data and reporting for lung cancer. 6. Number of downloads recorded for “Lung Cancer in Australia” 
and “Report  to the Nation on Lung Cancer”  
Increasing engagement and effective partnerships for 
the delivery of improved lung cancer care. 
7. Number of conjoint activities/partnerships with other cancer 
organisations in which the NLCP has a leadership role 
8. Number of NLCP projects and engagement activities 
demonstrating alignment with the CA National Framework for 
Consumer Involvement in Cancer Control 
9. Number of NLCP projects that have evidence of formal 
collaboration with organisations external to CA 
 10. Departmental actual expenditure in a financial year comes within 
10% of the original budget 
                                               
2 Tune, D. (2010) Speaking Notes: Evaluation: Renewed Strategic Emphasis. Department of Finance and Deregulation.  
Available at http://www.finance.gov.au/presentations/docs/speaking-notes-for-David-Tune-presentation-18-08-
2010.pdf accessed 23 March 2011. 
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1.2.2 Program logic and objectives 
Developing the program logic is an important first step in an evaluation as it helps to make explicit 
the program’s design and what the program is trying to achieve.  The program logic for NLCP has 
been documented separately and is included as Appendix 13.  A summary diagram is provided in 
Figure 1 below. 
 
The program logic also drives the evaluation framework.  This logic model establishes the links 
between the Program’s inputs, activities, outputs, outcomes and impact.  For example, one way of 
thinking about ‘appropriateness’ is by asking the question: ‘Is the NLCP doing the right things?’  A 
logic model can test the assumptions behind the activities in train and the causal link between the 
strategies chosen and the desired outcomes. 
 
The NLCP has three core objectives which guide the projects that are funded: 
 Increase research to build the evidence around lung cancer 
 Increase support and guidance for health professionals  
 Improve data and reporting for lung cancer. 
 












These are listed in the 
NLCP Work Plan and 
include approximately 18
diverse projects linked
to each short term
objective. 
Program Based 
Include investments in 
developing a robust 
national program e.g. 
development of the 
National Lung Cancer 
Advisory Group, and 
efforts that contribute to 
the organisational goals 
of Cancer Australia e.g.
support for the PdCCRS
Objective 1
Increase research to
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3 Thompson C, Samsa P and Eagar K (2011) Evaluation Services for Cancer Australia’s National Lung Cancer Program: 
Program Logic, Centre for Health Service Development, University of Wollongong. 
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The NLCP as an initiative of Cancer Australia has a role in national leadership and coordination.  
Consequently an additional opportunistic objective arises from the way the NLCP works with 
organisations and jurisdictions which is to: 
‘Increase engagement and effective partnerships for the delivery of improved lung cancer care’.4 
1.2.3 Cancer Australia Outcomes Hierarchy 
Cancer Australia was established to benefit all Australians who are diagnosed with cancer, their 
families and carers.  Cancer Australia has four key outcomes which each program area 
contributes to.  These outcomes are to generate: 
 Improvements in national coordination of cancer control and advice to Government 
 Improvements in cancer outcomes across the continuum of care 
 Improvements in the delivery of cancer care and the patient experience 
 Improvements in community knowledge that have the potential to impact on cancer outcomes.5 
 
Cancer Australia has identified how the organisation’s inputs and outputs as a whole can 
progressively build to generate improved health outcomes for the Australian community, (refer to 
Figure 2). 
 
This hierarchy of outcomes shows that before higher order health outcomes can be achieved, 
such as reduced mortality and the reform of systems and policy, there are preceding steps or 
‘foundation’ activities that need to be completed.  The work of the NLCP in its first phase of 
operation has concentrated on these base building blocks or ‘foundation’ activities. 
 




                                               
4Cancer Australia Lung Cancer Program.  Available at http://canceraustralia.gov.au/about-us/priorities-and-
programs/lung-cancer-program accessed 29 July 2011. 
5 Australian Government, Cancer Australia (August 2011). Cancer Australia: Strategic Plan 2011 – 2014, pp.19-20. 
6 Ibid, p. 22. 
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2 Evaluation strategy 
The evaluation strategy has been designed to allow a judgment as to how successfully the NLCP 
has been implemented, whether the desired results have been achieved and what lessons have 
been learnt that will lay the ground-work for the future. 
 
This program level evaluation does not seek to make judgements about the quality of outputs of 
individual projects.  The program-level evaluation will, in many respects, be a ‘roll-up’ of project 
achievements, constraints and successes, driven from the perspective of the evaluation 
framework.  Given the diversity of projects there are no common outcomes that can be identified 
across all projects, rather what is important is that projects align with the objectives of the NLCP 
and are implemented as intended. 
2.1 Elements of the evaluation 
The cancer community is diverse and the NLCP aims to achieve improvements for consumers, 
health providers and the broader health system, each of which needs to be considered in the 
evaluation: 
 Level 1: Impact on, and outcomes for, consumers (lung cancer patients, families, carers, 
friends, communities) 
 Level 2: Impact on, and outcomes for, health providers (professionals, volunteers, 
organisations) 
 Level 3: Impact on, and outcomes for, the system (structures and processes, networks, 
relationships). 
Figure 3 National Lung Cancer Program - Evaluation Elements 
Evaluation 
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The evaluation framework is built around six program elements: program delivery, program impact, 
sustainability, capacity building, generalisability and dissemination.  Not all elements are relevant 
to every project and objective of the NLCP.  The shading in Figure 3 is to indicate that the main 
focus of program delivery for the NLCP in this first funding phase, is in supporting health 
providers/professionals (Level 2).  This will in turn impact on people with lung cancer and the 
system for lung cancer control. 
 
The concepts of sustainability, capacity-building, generalisability and dissemination are mainly 
issues for the delivery of the NLCP at Level 2.  A brief explanation of these six areas is provided 
below. 
2.1.1 Program delivery 
Program delivery (implementation) includes what was done and how it was done.  Through 
interviews with key stakeholders and review of project documentation it is possible to explore the 
lessons learned about program implementation.  The NLCP has funded a series of projects that 
comprise the primary work or outputs of the program; a current project list is included as Appendix 
2. 
2.1.2 Program impact 
The program as a whole is aiming to have an impact at three levels: the level of the consumer, 
health service provider and broader health or cancer control system.  Individual projects within the 
program may be aiming to have an impact at one, two or all three of these levels.  As the projects 
are all quite different in nature it is logical to group the achievements in relation to each of the key 
program objectives. 
2.1.3 Sustainability 
The various definitions of sustainability coalesce around two main ideas - sustainability of the 
direct improvements made as part of a program, and the sustainability of the techniques and 
approaches learnt as part of the program as well as any indirect benefits.  Evaluation of 
sustainability is closely aligned with the issue of capacity building (e.g. increased capability and 
skills, increased resources) and any changes in structures and systems that ‘anchor’ or embed 
changes and facilitate sustainability.   
 
Several projects funded through the NLCP are not intended to be sustained.  They have 
contributed to short term outputs and may inform future initiatives but were not designed to be 
ongoing.  An example is the provision of travel grants for specialist lung care nurses to attend the 
14th World Conference on Lung Cancer.  This one-off activity aimed to build the capacity of these 
nurses to contribute to the organisation of the next World Conference on Lung Cancer as it will be 
held in Australia in 2013.  Due to the short life of the NLCP and implementation stage of many 
projects, sustainability is not a major focus of this evaluation. 
2.1.4 Capacity building 
Within the context of the NLCP, specifically the objectives of the program, capacity building has 
two main components: 
 Developing resources such as clinical guidelines, resources and other materials to support 
evidence-based practice. 
 Other activities to improve the ongoing capacity of the NLCP e.g. development of a lung 
cancer dataset and the Wiki platform. 
 
Where possible data will be collected to demonstrate the extent to which the program has built 
capacity in these areas. 
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2.1.5 Generalisability 
As one program within Cancer Australia, the NLCP aims to transform data and information into 
knowledge that can be applied in different contexts.  This issue can be examined by looking at 
how the NLCP might leverage off the broader organisation of Cancer Australia and conversely 
how the NLCP contributes to the achievements of Cancer Australia.  By reviewing the outputs of 
the NLCP and seeking the opinion of those involved in the program it will also be possible to 
investigate the extent to which the lessons learnt may be applied elsewhere. 
2.1.6 Dissemination – sharing of knowledge 
The issue of dissemination (who else learnt about the projects?) is closely linked to the issue of 
generalisability (are the lessons useful for someone else?).  The capacity of the NLCP to 
communicate about successful projects, throughout the wider cancer control sector, is important.  
This includes examination of the formal and informal mechanisms and processes for disseminating 
improvements. 
2.2 Appropriateness, Efficiency and Effectiveness 
In addition to the six program elements described in Section 2.1, the evaluation framework also 
needs to capture data that will explain how the NLCP has addressed the Australian Government’s 
requirements for appropriateness, efficiency and effectiveness. 
 
One way of thinking about ‘appropriateness’ is by asking the question: ‘Is the NLCP doing the right 
things?’  Appropriateness can be explored through the following questions: 
 Is the program consistent with Government priorities? 
 Is there still a need for this program; are there any alternative strategies to address the need? 
 What are the consequences of not continuing this program? 
 
Efficiency is defined as the extent to which the use of inputs is minimised for a given level of 
outputs, or outputs are maximised for the given level of inputs.  Efficiency is concerned with: 
 inputs – the resources used 
 the processes by which the program is delivered 
 outputs – the deliverables or products delivered by the program (for example, number of 
resources delivered, scholarships or grants awarded, health providers who accessed training 
etc.) 
 
Effectiveness describes the extent to which the program’s outputs have made a positive 
contribution to the specified outcome.  Effectiveness indicators are used to assess the degree of 
success in achieving outcomes.  Evaluating effectiveness involves asking the questions: 
 Which factors affect achievement of outcomes? 
 Are there any cause-effect interpretations as to whether the outcomes were caused by the 
program, or caused by external factors? 
 Were there any unanticipated outcomes which are contributing to the achievement of 
objectives or impacting negatively on consumers or health providers? 
Evaluation questions that will address appropriateness, efficiency and effectiveness are integrated 
throughout the evaluation framework.  An example of how these issues are addressed is provided 
in Table 2 
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Table 2 Addressing Appropriateness, Efficiency and Effectiveness 
 
 
FOCUS EVALUATION QUESTIONS 
APPROPRIATENESS 
Current government priorities Is the program consistent with Government priorities? 
Key program initiatives Is there an optimal mix of individual initiatives that could meet 
overall Program objectives? 
Key program initiatives Are the individual initiatives themselves appropriate? 
Continuing need Is there still a need for this program?  Has the burden of disease 
generated by lung cancer diminished? 
Key program initiatives Are there any clear gaps in the Program that might need to be 
filled by additional projects? 
Australian government funding Is the Program likely to continue in the absence of government 
funding? What are the consequences of not continuing this 
program? 
Possible improvements What are some possible improvements that might be 
considered to increase Program appropriateness and/or 
sustainability? 
EFFICIENCY 
Duplication Is there any duplication in Program initiatives that might be 
reduced to improve efficiency? 
Administration Could the inputs, processes, outputs and administration of the 
Program and its projects be improved? 
Possible improvements What are some possible improvements that might be 
considered to increase Program efficiency? 
EFFECTIVENESS 
Program objectives To what extent has the Program and individual funded projects, 
been successful in achieving agreed objectives? 
Outcomes What are the key outputs and short term outcomes achieved as 
a result of funding the Program? 
Contribution to organisational goals Has the NLCP added value to the work of CA in its plan to roll 
out tumour-based programs?  What are the lessons learnt for 
CA in expanding its work? 
Possible improvements What are some possible improvements that might be 
considered to improve Program effectiveness? 
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3 Evaluation framework 
The evaluation framework has been designed to focus on the building blocks of the NLCP which 
will be contributing to the next project phase.  These activities provide the foundation necessary to 
establish and maintain the program e.g. the development of the National Lung Cancer Advisory 
Group.   
 
Most of the projects funded in this first phase of the NLCP will only be in the initial stages of 
implementation at the time of the evaluation, therefore evidence from this phase of the program 
will mainly be output related.  The program logic has been developed to ensure that program 
outputs, where appropriate, can be built upon and contribute to medium and longer term 
improvements in health outcomes. 
3.1 Target groups 
The key target groups being addressed by the Program are consumers, health providers and 
partner organisations with which the NLCP aims to collaborate.  Not every project addresses all 
target groups. 
 
The consumers include: 
 People with lung cancer, their carers and families 
 The general community. 
 
The providers include: 
 Primary care providers (including GPs, Practice Nurses, allied health professionals, Aboriginal 
Health workers etc.) 
 Specialist lung service providers (including respiratory physicians, oncologists, surgeons, lung 
nurses etc.). 
 
The partner organisations include: 
 Organisations with a focus on cancer consumers 
 Organisations with a focus on health service providers working in the lung cancer or related 
fields. 
 
The NLCP also has responsibility for ensuring that it extends its reach to disadvantaged 
communities including those living in rural and remote Australia, people of Aboriginal and Torres 
Strait Islander backgrounds, people of Culturally and Linguistically Diverse backgrounds and those 
of low socio-economic status. 
 
3.2 Evaluation questions 
A range of evaluation questions are provided in  
 
 
Table 3 that cover the evaluation elements described in Section 2.1.  These questions are linked 
to the Program objectives and short term outcomes specified in the program logic.  They aim to 
address the outputs and outcomes of the NLCP for consumers, service providers and the broader 
health system.  Each evaluation question is also coded against the three lapsing program criteria: 
“A” for appropriateness, “EI” for efficiency and “E” for effectiveness. 










Table 3 Evaluation Framework to Address NLCP Objectives 
 
 
OBJECTIVES EVALUATION QUESTIONS MEASURES DATA SOURCES 
Level 1:     Processes, impacts and outcomes for consumers (cancer sufferers, families, carers, friends, communities) 
Increasing research 
to build the evidence 






for the delivery of 




Were appropriate consumer 
projects selected to be 
funded? 
 
Percentage of funded consumer 
related projects that align with 
NLCAG priorities 
 
Documentary review of 
NLCAG minutes and 
consumer project 
plans/progress reports 
Stakeholder interview: CA 
CEO, Chair & NLCAG 
members, Program staff  
 
EI DELIVERY 
Were the consumer projects 
completed as intended? 
 Translation of lung 
cancer DVD 
 Review of lung cancer 
patient information 
 Promotion of key 
messages to the 
community on symptoms 
and early detection of 
lung cancer  
 
Percentage of consumer 
projects that were completed on 
time and on budget 
 
Project records, (milestones, 
deliverables) 
Budget reports 
EI Were consumers involved in 
the NLCP? 
Level of compliance/alignment 
of projects with the principles of  
the National Framework for 
Consumer Involvement in 
Cancer Control 




NLCAG; CA personnel; 
other nominated groups. 
 
E IMPACT 
Were lung cancer DVDs for 
consumers produced in 
community languages? 
 
Number of lung cancer related 
DVDs produced in each of 
twelve community languages  
Project records 
E Did health professionals have 
improved access to evidence 
based consumer resources? 
 
Number of downloads from 
Australian Lung Foundation 
web-site 
Website analysis 
E What efforts where made to 
incorporate the requirements 
of ATSI and CALD consumers 
in the Stigma and Nihilism and 
Model of Care projects of the 
NLCP? 
 
Evidence of effort to address 
the requirements of ATSI and 
CALD consumers in relevant 
projects of the NLCP 
Audit tool for use prior to 
contract finalisation 
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OBJECTIVES EVALUATION QUESTIONS MEASURES DATA SOURCES 
E DISSEMINATION 





Numbers of workshops, 
presentations, publications 
Dissemination Log 
Level 2:     Processes, impacts and outcomes for providers (professionals, volunteers, organisations) 
Increasing research 
to build the evidence 
around lung cancer  
 
A DELIVERY 
Were the appropriate research 




Level of alignment with 
documented NLCAG research 
priorities 
 
Documentary review of 
NLCAG minutes and 
research project 
plans/progress reports 
Stakeholder interview: CA 
CEO, Chair & NLCAG 
members, Program staff 
EI DELIVERY 
Were the research projects 
completed as intended? 
 Research and report on 
the effects of stigma and 
nihilistic views on lung 
cancer outcomes 
 Model of Care for the 
management of lung 
cancer 
 PdCCRS – Lung cancer 
research priorities 
(Project 1: Alternative 
lengthening of telemeres 
in lung cancer) 
 PdCCRS – Lung cancer 
research priorities 
(Project 2: Identifying 
therapeutic targets by 
profiling DNA repairing 
lung cancer) 
 PdCCRS - Lung cancer 
research priorities 
(Additional projects in 
alignment with agreed 
lung cancer research 
priorities 2011-2013) 
 Lung cancer risk factor 
research 
 Investigating the 
symptoms in lung cancer 
 
Percentage of research projects 
completed on time and on 
budget 








What impact did the PdCCRS 
research reports generate? 
Number of items submitted for 
publication 
Number of items placed on the 




E What impact did the 
systematic review on the 
effects of stigma and nihilistic 
views on lung cancer 
outcomes have within the 
Australian cancer control 
sector? 
Systematic review published in 
a peer reviewed journal 




Citation report (note, 
citations may not appear for 
some time after publication) 
E Did all research projects 
contribute to building the 
evidence around lung cancer? 
Number of research projects 
that have prepared and/or 
submitted a publication 
Project records 
Review with CA staff 
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OBJECTIVES EVALUATION QUESTIONS MEASURES DATA SOURCES 
E DISSEMINATION 




Number of conference 
presentations/workshops by 
NLCP staff, and by Projects 
related personnel 
 
Number of publications 













Were appropriate support and 




Level of alignment with 
documented NLCAG priorities 
 
Documentary review of 
NLCAG minutes and 
relevant project 
plans/progress reports 
Stakeholder interview: CA 
CEO, Chair & NLCAG 
members, Program staff 
EI DELIVERY 
Were the support and 
guidance projects delivered as 
intended? 
 The development and 
validation of clinical 
indicators for optimal lung 
cancer care 
 Updating the 2004 
Clinical Practice 
Guidelines for the 
prevention, diagnosis and 
management of lung 
cancer 
 Travel grants for IASLC 
14th World Conference 
on Lung Cancer in 
Amsterdam 
 Translating Research into 
Practice (TRIP) clinical 
fellowship for lung cancer 
 Lung Cancer Spaced 
Education program for 
GPs  
 Development of a Lung 
Cancer Risk factor 
assessment tool for 
General Practitioners  
Percentage of support and 
guidance projects completed on 








What impact did the support 
and guidance projects have? 
Evidence of improved 
information, guidelines and 
support for GPs in lung cancer 
management 
Contribution of the NLCP to 
increased confidence, 
knowledge and capacity of 
health professionals to manage 
lung cancer within the primary 
care setting 
Project report records 
relating to providers using 
new models of care, 
guidelines and consumer 
resources 





E Was the Lung Cancer Spaced 
Education program for GPs 
used? 
Numbers of GPs completing 
education program actvities 
Project documentation and 
records 
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OBJECTIVES EVALUATION QUESTIONS MEASURES DATA SOURCES 
E CAPACITY BUILDING 
Did the Travel Grants project 
improve the capacity of the 
service system? 
Number of lung cancer nurses 
participating in travel grants 
projects 
Number of lung cancer nurses 
with a travel grant who are 
contributing to the 15th World 
Conference on Lung Cancer in 
Australia 
Stakeholder interview: ALF, 
NLCP staff, NLCAG 
members 
 
Survey -  lung cancer nurse 
network 
E DISSEMINATION 
Did the Translating Research 
into Practice (TRIP) clinical 
fellowship for lung cancer 
disseminate knowledge to the 
service sector? 
Number of knowledge 
dissemination activities 
CA staff, NLCP staff, 
NLCAG members, TRIP 
fellows 
Dissemination Log 
Improving data and 




Were appropriate data and 
information projects selected 
to be funded? 
 
 
Level of alignment with 
documented NLCAG priorities 
 
Documentary review of 
NLCAG minutes and 
relevant project 
plans/progress reports 
Stakeholder interview: CA 
CEO, Chair & NLCAG 
members, Program staff 
EI DELIVERY 
Were the data projects 
delivered as intended? 
 Development and pilot 
testing of Lung Cancer 
Data Set Specification 
 Capturing information on 
clinical stage, metastases 
at diagnosis and cancer 
recurrence employing IT 
solutions 
Percentage of support and 
guidance projects completed on 








What were the major lessons 
learned through the 
development and 
implementation of the data 
and reporting projects? 
Document unintended 
consequences for Cancer 
Australia 
Document major lessons 
learned and program gaps 
Stakeholder discussion, CA 




How will the data and 
reporting improvements be 
sustained? 
 
Level of partnerships instituted 
to support adoption of data and 
reporting initiatives 
Final version of dataset 
endorsed by the National Data 
Standards Group  
Documentary review of 
NLCAG minutes and 
relevant project 
plans/progress reports 
Stakeholder interview: CA 
CEO, Chair & NLCAG 
members, Program staff 
Dissemination log 
E CAPACITY BUILDING 
Was there improved access to 
data relating to lung cancer? 
Number of downloads from 










for the delivery of 
improved lung cancer 
care. 
EI DELIVERY 
How frequently has the 
NLCAG met and what is the 
level of participation? 
 
Number of meetings of the 
NLCAG and pattern of 
attendance of members 
 
Documentary review of 
NLCAG minutes/papers 
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OBJECTIVES EVALUATION QUESTIONS MEASURES DATA SOURCES 
 E/A IMPACT 
What contribution has the 
NLCAG made to the work of 
the NLCP? 
Evidence of engagement with 
NLCAG members 
Evidence of consistency of 
program initiatives with 
Australian Government priorities 
Stakeholder interview, CA 
staff, NLCP staff, NLCAG, 
Projects staff 
Documentary sources: 
Portfolio Budget Statements 
 
 What is the contribution of 
expert clinicians and service 
providers to the NLCP? 
Participation of experts/service 
providers in project working 
groups 
Attendance of members of the 
NLCAG at advisory group 
meetings 
 
Meeting attendance audit 
tool 
 What other partnerships has 
the NLCP developed through 
the work of the Program? 
 
Evidence of increased 
networking and collaboration 
within the lung cancer control 
community 
Stakeholder interview, CA 




Level 3:     Processes, impacts and outcomes for the system (structures, processes, networks, relationships) 
Increasing research 
to build the evidence 
around lung cancer  
 
Increasing support 







Improving data and 




Were the data and reporting 
projects delivered as 
intended? 
 AIHW Report: Lung 
Cancer in Australia 
 Report to the Nation on 
Lung Cancer in Australia  
Percentage of data and 
reporting projects completed on 
time and on budget 
 
 




Was there increased 
knowledge of the extent and 
effect of lung cancer amongst 
the Australian public and 
policy makers? 
Number of downloads of reports 
“Lung Cancer in Australia” and 
“Report to the Nation on Lung 








for the delivery of 
improved lung cancer 
care. 
A DELIVERY 
Was the balance of effort 
appropriate in the allocation of 
funds between the key 
program objectives? 
Percentage of Program 
expenditure per core objective 
 
Document analysis of 
project expenditure 
Stakeholder interview: NLCP 
staff, NLCAG members 
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OBJECTIVES EVALUATION QUESTIONS MEASURES DATA SOURCES 
 EI DELIVERY 
Did the NLCP engage and 












Did the NLCP engage with 
other jurisdictions through the 
Model of Care project and 








 Medical Oncology Group 
of Australia 
 Clinical Oncological 
Society of Australia 
Other Professional Networks 
 ALF (specialist lung 
nurses) 





 State Jurisdictions 
Documentary records e.g. 
minutes of meetings  
Stakeholder interviews 
Key partner organisations, 
survey (relationship tool) 
A IMPACT 
Is there still a need for this 
program? 
Evidence of burden of disease 
generated by lung cancer in the 
Australian community 
Documentary sources 
including NLCP publications 
developed through AIHW 
A IMPACT 
Is the NLCP likely to continue 
in the absence of government 
funding? 
Perceptions of the 
consequences of not continuing 
this Program amongst key 
stakeholders 
Stakeholder interview: CA 
CEO and Chair,  NLCP staff, 
members of the NLCAG 
Surveys -Use of relationship 
tool with key partners 
E IMPACT 
Did the NLCP increase 
networking and collaboration 
within the lung cancer control 
community? 
Perceptions of networking and 
collaboration within the lung 
cancer control community 
amongst the NLCP and key 
stakeholders 
Stakeholder interview: CA 
CEO and Chair,  NLCP staff, 
members of the NLCAG 
Surveys -Use of relationship 
tool with key partners 
A/E SUSTAINABILITY 
What are some possible 




Perceptions of areas of  focus 
for the future from key 
stakeholders 
Stakeholder interview: CA 
CEO and Chair,  NLCP staff, 
members of the NLCAG 
Surveys -Use of relationship 
tool with key partners 
EI Is there any duplication in 
Program initiatives that might 
be reduced to improve 
efficiency? 
Evidence of project duplication 
within CA 
Stakeholder interview: CA 
CEO and Chair,  NLCP staff, 
E DISSEMINATION 
Has the groundwork been 
developed for further 
dissemination of work that is 
completed? 
Description of  foundation 
activities contributing to the 
knowledge hub within CA 
Stakeholder interview: CA 
CEO and Chair,  NLCP staff, 
members of the NLCAG 
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4 Methodological issues and data sources 
Clear, well-articulated questions form the basis of designing the evaluation, however not all 
questions to be answered by the evaluation can be made explicit at the beginning of the 
evaluation.  Some questions will emerge over the course of the evaluation as data is collected and 
analysed.  Some questions may need to be modified as the evaluation progresses, usually due to 
the lack of appropriate means to collect the required data. 
 
One issue in understanding the impact of the NLCP relates to the level of evidence.  This can 
either be at the level of ‘beyond reasonable doubt’ typically used in scientific research, or at the 
level of ‘on the balance of probabilities’ typically used by policy makers and decision makers.  The 
aim is to frame the interpretation of the data, both quantitative and qualitative, according to the 
latter. 
4.1 Sources of data 
The primary data sources listed in the evaluation framework include documentary sources, 
stakeholder interviews, audit tools, surveys, dissemination logs, media monitoring and web 
analysis.  Each is described in turn below. 
4.1.1 Documentary sources 
A range of documents will be analysed during the evaluation to provide evidence of 
appropriateness, efficiency and effectiveness.  These include internal documentation relating to 
the policies and operation of CA and the NLCP as well as external Government policies, 
documents and legislation relevant to the area of cancer control. 
 
A key documentary source includes the project plans, progress and budget reports.  These reports 
will be examined to see whether project milestones were met and projects were completed on 
budget.  The review of these reports may be supported by the development of a project checklist 
and/or reporting template. 
 
Minutes of meetings arranged and attended by NLCP staff with other lung cancer control agencies 
will be reviewed to understand the nature of NLCP engagement with these agencies.  The records 
of meetings of the NLCAG are another valuable resource that captures the work and decisions of 
this group. 
4.1.2 Stakeholder interviews 
Interviews are a rich source of qualitative data and allow more complex issues to be investigated 
and understood.  Therefore interviews with a range of key stakeholders will be an important data 
collection tool.  The selection of interviewees will be based on the need to: 
 inform the program-level evaluation 
 guide and check the validity of findings from data analysis 
 check the quality of the data collected by other means 
 inform the dimensions of sustainability and dissemination 
 understand the process of program development and establishment. 
 
Potential interviewees will be invited to consent and provided with a Participant Information Sheet 
that will detail the purpose of the interview, and how the information gathered in the interview will 
be used and stored. 
 
Interviews that are likely to be short will be conducted by phone and recorded by the taking of 
notes.  In some cases an email response will be appropriate and will serve as the data collection 
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method.  Longer interviews may need to be recorded digitally.  The interviewer will make notes as 
soon as possible after each interview to record their own observations and key points.  Some time 
later the interviewer will listen to the recording and extract the salient points and quotations from 
the interviews.  Recordings will be retained to allow for further analysis at a later data if there is a 
need to do so. 
 
In some cases it may be more efficient to use on-line survey tools when similar questions are to be 
asked of a larger group of stakeholders. 
The National Lung Cancer Advisory Group 
The National Lung Cancer Advisory Group guides the NLCP and consists of a range of clinicians, 
bureaucrats and consumers.  The opinions of Group members will be sought on the range of 
activities of the Program and how these activities align with priorities set by NLCAG.  Their 
opinions may be sought by individual interview, group discussion, or via an on-line survey. 
Staff of Cancer Australia external to the NLCP 
Several staff of CA have ongoing contact with the work of the Program.  Their views will be sought 
on how the project management of the NLCP may be improved, the effectiveness of the funded 
projects and how the work of the NLCP aligns with the work of Cancer Australia, for example in 
relation to the PdCCRS and mechanisms for consumer engagement.  This information may be 
sought by interview or an on-line survey. 
NLCP staff 
The staff with day to day responsibility for the operations of the NLCP are an important resource.  
Their views will be sought on the effectiveness of the projects, and how improvements can be 
made, for example to consumer involvement.  Because of the depth of their knowledge, this will be 
best done by interview. 
Cancer Australia CEO and Chair 
These individuals are well positioned to comment on the strategic impact of the NLCP and how the 
NLCP currently contributes, and how in the future its work is planned to contribute, to the work of 
Cancer Australia.  Their input on these issues and how the NLCP aligns with Australian 
Government policies and priorities will be sought by interview. 
Cancer Australia’s National Consumer Advisory Group 
The National Consumer Advisory Group provides formal advice to Cancer Australia on matters of 
concern to consumers.  Group members may have contributed at different times to the work of the 
NLCP.  If appropriate they will be asked to provide feedback on the appropriateness of the work of 
the NLCP for consumers, and how it has impacted on consumers.  This input will be sought by an 
on-line survey. 
Project staff 
The vast majority of NLCP projects have been contracted out to a diverse group of researchers, 
consultants and health service providers.  It may be appropriate to gain the input of a sample of 
these project contributors in relation to how the projects could have been implemented more 
effectively and efficiently.  This will be done via an on-line survey. 
Key partner organisations 
A number of organisations will be identified as key partner organisations by the NLCP and Cancer 
Australia, for example, the NLCP works closely with the Australian Lung Foundation and the 
Cancer Council of Australia.  These organisations will be interviewed as to whether the NLCP has 
increased networking and collaboration within the lung cancer control community. 
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4.1.3 Surveys 
Online surveys will be used to determine the effectiveness of NLCP activities in certain areas.  
These will be developed using the Survey Monkey application as it is web based and can 
efficiently collate quantitative survey results. 
 A relationship tool may be used with other lung cancer control agencies to identify any 
perceived changes in their relationship with the NLCP, and networking and collaboration 
between agencies in this sector 
 A range of service providers could be surveyed to explore their use of resources provided by 
the NLCP.  These service providers may include: 
 Professional associations such as the Royal Australian College of General Practitioners, 
Clinical Oncological Society of Australia etc. 
 Special interest service providers such as the Australian Lung Foundation 
 Non-government organisations such as Cancer Council Australia 
 Australian Government and State Government jurisdictions (in relation to specific and 
relevant projects) 
Another option may be to identify users of the NLCP web-site and ask them to participate in a 
survey to evaluate web based information resources relating to lung cancer. 
4.1.4 Audit tools 
The analysis of documentary and web sources can be streamlined through the use of an 
appropriate audit tool.  In some cases standardised and validated tools may be available; in other 
instances it may be useful to produce customised audit tools.  These tools will be used to structure 
the assessment of Program performance in several areas.  For example the level of consumer 
involvement in projects and/or efforts to incorporate the requirements of disadvantaged groups 
could be measured through the use of consumer involvement audit tools. 
4.1.5 Dissemination logs 
It may be useful to track dissemination activities of projects as they proceed over the ensuing 
months.  A dissemination log could be created to assist NLCP staff to keep records of a range of 
project related dissemination activities e.g. conference presentations; resource distribution, etc. 
4.1.6 Media monitoring and web analysis 
Usage of the NLCP web-site could be analysed to determine downloads of resources provided on 
the web-site.  This could be restricted to key publications such as the proposed Australian Institute 
of Health and Welfare (AIHW) report “Lung Cancer in Australia”.  AIHW provides a satisfaction or 
‘publication effectiveness’ survey for documents downloaded from their web-site.  This could also 
be linked to the CA web-site and will provide feedback on users’ satisfaction.   Google Scholar can 
be used to track citations of any scholarly publications that arise out of NLCP projects.  There 
should also be an expectation that any publications will be jointly produced with CA. 
 
Media monitoring may be used to identify mentions of the work of the NLCP that are broadcast in 
the mainstream media in order to determine the reach of NLCP messages to the general public.  
CA may already have a media monitoring service engaged. 
4.2 Next steps 
The next step in this process is refinement of the evaluation questions and key performance 
indicators in collaboration with staff or the NLCP.  It will then be possible to develop the tools to 
support data collection for the evaluation. 
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Appendix 2 National Lung Cancer Program Project List 
 
Project Number Project Title 
1 Research and report on the effects of stigma and nihilistic views on lung cancer outcomes 
2a PdCCRS – Lung cancer research priorities (Project 1: Alternative lengthening of telemeres in lung 
cancer) 
2b PdCCRS – Lung cancer research priorities (Project 2: Identifying therapeutic targets by profiling 
DNA repairing lung cancer) 
2c PdCCRS - Lung cancer research priorities (Additional projects in alignment with agreed lung 
cancer research priorities 2011-2013) 
3 Lung cancer risk factor research 
4 Model of Care for the management of lung cancer 
5 Updating the 2004 Clinical Practice Guidelines for the prevention, diagnosis and management of 
lung cancer 
6 Investigating the symptoms in lung cancer 
7 Translation of lung cancer DVD 
8 Review of lung cancer patient information 
9 Travel grants for IASLC 14th World Conference on Lung Cancer in Amsterdam 
10 Translating Research into Practice (TRIP) clinical fellowship for lung cancer 
11 Development and pilot testing of Lung Cancer Data Set Specification 
12 AIHW Report: Lung Cancer in Australia 
13 Capturing information on clinical stage, metastases at diagnosis and cancer recurrence employing 
IT solutions 
14 Report to the Nation on Lung Cancer in Australia – This will be a report derived from the AIHW 
report that will provide easily accessible information about advances in cancer control for the 
general public including the media 
15 The development and validation of clinical indicators for optimal lung cancer care – This will be a 
suite of clinical indicators for best practice in lung cancer that will be validated in the clinical 
setting. 
16 Promotion of key messages to the community on symptoms and early detection of lung cancer - 
This will be printed and on-line information resources for people affected by lung cancer to support 
the early detection and identification of lung cancer symptoms. 
17 Development of a Lung Cancer Risk factor assessment tool for General Practitioners -  this will 
include undertaking a feasibility of developing a risk factor assessment tool for GPs and if feasible 
development of the tool. 
18 Lung Cancer Spaced Education program for GPs  - This will include spaced education activities 
that will be linked to Cancer Australia resources developed under the GP guide project 
  
 

 
 
 
